Short answer · Medically reviewed summary · Last updated: 2026-04-07
Antisynthetase syndrome does not have a unique, dedicated ICD-10 or ICD-9 code; instead, it is typically classified under broader categories for idiopathic inflammatory myopathies. Clinicians often use ICD-10 code M33.2 (polymyositis with involvement of the lung) or M33.9 (dermatopolymyositis, unspecified) to capture the condition for medical billing and documentation. Why is there no specific ICD code for Antisynthetase syndrome? In the current medical coding systems, Antisynthetase syndrome is categorized as a subset of idiopathic inflammatory myopathies.
ICD10 code of Antisynthetase syndrome and ICD9 code
ICD-10 and ICD-9 codes for Antisynthetase syndrome, with classification details for clinicians, coders and patients.
Antisynthetase syndrome does not have a unique, dedicated ICD-10 or ICD-9 code; instead, it is typically classified under broader categories for idiopathic inflammatory myopathies. Clinicians often use ICD-10 code M33.2 (polymyositis with involvement of the lung) or M33.9 (dermatopolymyositis, unspecified) to capture the condition for medical billing and documentation.
Why is there no specific ICD code for Antisynthetase syndrome?
In the current medical coding systems, Antisynthetase syndrome is categorized as a subset of idiopathic inflammatory myopathies. Because the syndrome is complex and multi-systemic—involving the lungs, skin, joints, and muscles—it does not fit into a single, narrow diagnostic code. Medical coding is designed for billing and statistical tracking rather than capturing the full clinical nuance of Antisynthetase syndrome. Consequently, physicians must often use a combination of codes to accurately reflect the interstitial lung disease (ILD), myositis, and arthritis that define the clinical presentation of Antisynthetase syndrome.
How is a diagnosis of Antisynthetase syndrome confirmed?
The diagnosis is primarily clinical, supported by serological testing. A hallmark of Antisynthetase syndrome is the presence of anti-aminoacyl-tRNA synthetase antibodies, the most common being anti-Jo-1. Beyond blood work, clinicians rely on a combination of diagnostic criteria to confirm the presence of the condition:
- Serology: Identification of specific autoantibodies (e.g., anti-Jo-1, anti-PL-7, anti-PL-12).
- Pulmonary Function Tests: Assessment for interstitial lung disease (ILD), which is often the most significant predictor of prognosis.
- Imaging: High-resolution computed tomography (HRCT) of the chest to identify ground-glass opacities or fibrosis.
- Physical Exam: Observation of "mechanic’s hands" (hyperkeratosis and fissuring of the skin on the fingers), arthritis, and muscle weakness.
What is the clinical significance of the DiseaseMaps community data?
At DiseaseMaps.org, 36 people with Antisynthetase syndrome have joined the community and shared their experiences. This collective data is invaluable because Antisynthetase syndrome is a rare disease with significant variability in how it presents between individuals. Engaging with a community allows patients to compare notes on diagnostic journeys, treatment side effects, and daily management strategies for living with the condition.
What are the primary treatment goals for patients?
Management of Antisynthetase syndrome is multidisciplinary, usually requiring a rheumatologist, a pulmonologist, and a physical therapist. The primary goal is to suppress the overactive immune system to prevent further lung scarring and muscle damage. Corticosteroids are typically the first-line treatment, often followed by steroid-sparing agents such as mycophenolate mofetil, rituximab, or azathioprine to maintain long-term remission.
Next steps
- Consult with a rheumatologist specializing in connective tissue diseases to discuss your specific antibody profile.
- Request a baseline pulmonary function test and HRCT scan if you have been diagnosed with or suspect Antisynthetase syndrome.
- Connect with the 36 members at DiseaseMaps.org to share experiences and find support among those who truly understand the daily impact of this rare condition.
- Keep a symptom diary to track muscle fatigue, joint pain, or respiratory changes to share with your care team.
Medical disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.
References
- Orphanet: Antisynthetase syndrome (ORPHA:96144)
- NIH Genetic and Rare Diseases Information Center (GARD): Antisynthetase syndrome
- OMIM (Online Mendelian Inheritance in Man): Entry #610714 (Myositis, Inclusion Body, Associated with Antisynthetase Syndrome)
- The Myositis Association: Clinical overview of Antisynthetase Syndrome
